The agency said on Monday it would not object to commercial
manufacturers distributing and labs using new commercially developed
tests prior to the FDA granting a so-called Emergency Use
The agency also took steps toward speeding the development of
coronavirus test kits by giving states the authority to approve
tests developed in laboratories in the states. [nL1N2B969R]
(Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini
[© 2020 Thomson Reuters. All rights
Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.